Clearstead Trust’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.87K Buy
22
+3
+16% +$812 ﹤0.01% 721
2025
Q4
$4.77K Sell
19
-5
-21% -$1.33K ﹤0.01% 770
2025
Q3
$6.89K Sell
24
-8
-25% -$2.14K ﹤0.01% 683
2025
Q2
$8.4K Buy
32
+21
+191% +$5.11K ﹤0.01% 629
2025
Q1
$2.56K Buy
+11
New +$2.67K ﹤0.01% 732

Other funds holding LH

Clearstead Trust's LH Position: Q1 2026 in Review

Clearstead Trust increased its Labcorp (LH) stake by 16% in Q1 2026, buying an estimated $812 and bringing the position to 22 shares worth $5.87K. The position accounts for ﹤0.01% of the portfolio, ranked #721.

Clearstead Trust first reported a position in LH in Q1 2025 and has held it in 5 quarters since. The position peaked at $8.4K in Q2 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Clearstead Trust held 22 shares of Labcorp worth $5.87K as of Q1 2026.
  • Clearstead Trust bought 3 Labcorp shares in Q1 2026, an estimated $812.
  • Labcorp made up ﹤0.01% of Clearstead Trust's portfolio in Q1 2026, its #721 holding.
  • Clearstead Trust first reported a position in Labcorp in Q1 2025 and has held it in 5 quarters since.
  • Clearstead Trust's Labcorp position peaked at $8.4K in Q2 2025.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Clearstead Trust's 13F filing for Q1 2026, filed 6 May 2026.